Treating C3 glomerulopathy with eculizumab

Treating C3 glomerulopathy with eculizumab

Abstract Background C3 glomerulopathy (C3G) is a rare, but severe glomerular disease with grim prognosis. The complex pathogenesis is just unfolding, and involves acquired as well as inherited dysregulation of the alternative pathway of the complement cascade. Currently, there is no established ther...

Full description

Bibliographic Details
Main Authors: Thomas Welte, Frederic Arnold, Julia Kappes, Maximilian Seidl, Karsten Häffner, Carsten Bergmann, Gerd Walz, Elke Neumann-Haefelin
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Nephrology
Subjects:
C3 glomerulopathy
C3 glomerulonephritis
Dense deposit disease
Complement
Eculizumab
Online Access:http://link.springer.com/article/10.1186/s12882-017-0802-4

Internet

http://link.springer.com/article/10.1186/s12882-017-0802-4

Similar Items